Isoniazid Injection
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Isoniazid Injection is a sterile solution of Isoniazid in Water for Injection. It contains NLT 90.0% and NMT 110.0% of the labeled amount of isoniazid (C6H7N3O).
2 IDENTIFICATION
A. The retention time exhibited by isoniazid in the Sample solution corresponds to that of isoniazid in the Standard solution, as obtained in the Assay.
B.
Sample stock solution: Nominally 0.1 mg/mL of isoniazid in water prepared as follows. Transfer an equivalent to 50 mg of isoniazid from a volume of Injection to a 500-mL volumetric flask, and dilute with water to volume.
Sample solution: 0.01 mg/mL of isoniazid in water prepared as follows. Transfer 10.0 mL of Sample stock solution to a 100-mL volumetric flask, add 2.0 mL of 0.1 N hydrochloric acid, and dilute with water to volume.
Acceptance criteria: The UV absorption spectrum of the Sample solution exhibits maxima and minima only at the same wavelengths as that of a similar solution of USP Isoniazid RS, concomitantly measured.
3 ASSAY
Procedure
Mobile phase: 4.4 g/L of Docusate sodium in a mixture of methanol and water (600:400), and adjusted with 2 N sulfuric acid to a pH of 2.5. Standard solution: 0.32 mg/mL of USP Isoniazid RS in Mobile phase
Sample solution: Nominally 0.32 mg/mL of isoniazid in Mobile phase
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 4.6-mm × 25-cm; packing L1
Flow rate: 1.5 mL/min
Injection volume: 10 µL
System suitability
Sample: Standard solution
Suitability requirements
Column efficiency: NLT 1800 theoretical plates
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of isoniazid (C6H7N3O) in the portion of Injection taken:
Result = (rU/rS) × (CS /CU) × 100
rU = peak response of isoniazid from the Sample solution
rS = peak response of isoniazid from the Standard solution
CS = concentration of USP Isoniazid RS in the Standard solution (mg/mL)
CU = nominal concentration of isoniazid in the Sample solution (mg/mL)
Acceptance criteria: 90.0%–110.0%
4 SPECIFIC TESTS
pH 〈791〉: 6.0–7.0
Bacterial Endotoxins Test 〈85〉: Contains NMT 0.3 USP Endotoxin Unit/mg of isoniazid
Other Requirements: It meets the requirements in Injections and Implanted Drug Products 〈1〉.
5 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in single-dose or multiple-dose containers, preferably of Type I glass, protected from light. Labeling: Its package label states that if crystallization has occurred, the Injection should be warmed to redissolve the crystals before use. USP Reference Standards 〈11〉
USP Isoniazid RS

